Alexander Fudukidis | IR |
Spiro Rombotis | President, CEO & Executive Director |
Paul McBarron | EVP, Finance, CFO, COO, Secretary & Executive Director |
Judy Chiao | VP, Clinical Development & Regulatory Affairs |
Jotin Marango | Roth Capital Partners |
Wangzhi Li | Ladenburg Thalmann & Co. |
Good afternoon, and welcome to the Cyclacel Pharmaceuticals Fourth Quarter and Full Year 2018 Results Conference Call and Webcast. [Operator Instructions]. The company will also be accepting a limited number of questions submitted via e-mail to the address, ir@cyclacel.com. [Operator Instructions]. Please note that today's call is being recorded.